The Food and Drug Administration has issued emergency use authorizations for two monoclonal antibody treatments for COVID-19 – one produced by Eli Lilly and another by Regeneron. But emergency use authorization doesn't assure the drugs are effective.In this episode of Short Wave, NPR's daily science podcast, science correspondent Richard Harris explains how the new treatments work — and whether they could really make a difference for patients with COVID-19. Listen to more episodes of Short Wave on Apple Podcasts or Spotify.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Consider This from NPR
Transcribed and ready to explore now
We may be in an AI bubble. What does that mean?
16 Oct 2025
Consider This from NPR
Drowning in tariffs, American businesses try to stay afloat
10 Apr 2025
Consider This from NPR
Tariffs will boost prices a lot — here's how much
09 Apr 2025
Consider This from NPR
What will it take to get measles under control?
08 Apr 2025
Consider This from NPR
They want America to have more babies. Is this their moment?
07 Apr 2025
Consider This from NPR
How Deportations Work
06 Apr 2025
Consider This from NPR